Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Dec;17(102):621-4.

[Efficiency and safety of citalopram and venlafaxine in treatment of depressive disorders in elderly patients]

[Article in Polish]
Affiliations
  • PMID: 15771136
Clinical Trial

[Efficiency and safety of citalopram and venlafaxine in treatment of depressive disorders in elderly patients]

[Article in Polish]
Piotr Gałecki et al. Pol Merkur Lekarski. 2004 Dec.

Abstract

Depressive disorders in people older than 65 years seem to be a serious medical and social problem in many countries. The aim of the study was to evaluate efficiency and safety of citalopram and venlafaxine in treatment of depression in elderly patients.

Material and methods: 89 elderly patients with a serious depressive episode were involved in the study. Observation was carried out for 42 days. The clinical state of patients was assessed by Hamilton rating scale (HAM-D), a geriatric depressive scale (GDS) and a clinical general impression scale (CGI). Cognitive functions were examined by Mini-Mental scale. 44 patients took citalopram, and 45 patients took venlafaxine.

Results: On the 42nd day of treatment, citalopram therapy appeared successful in 34 (77.3%) patients, while venlafaxine therapy was successful in 30 (66.6%) patients. Citalopram was significantly more efficient than venlafaxine during the first 21 and 28 days of treatment. Neither drug caused disturbances of cognitive functions in the examined groups.

Conclusions: 1. Citalopram and venlafaxine are similarly efficient in treatment of depressive disorders and are well tolerated by elderly patients. 2. The onset of therapeutic activity of citalopram is potentially faster in depressive patients older than 65 years.

PubMed Disclaimer